Tiffany A. LaFortune
- Molecular Biology
- Oncology top 10%
- Genetics top 5%
- Cancer Research top 10%
- Cell Biology top 10%
- Co-authors
- Dimpy KoulJohn de GrootW.K. Alfred YungNingyi TiaoYuji PiaoSauveur-Michel MairaVanessa MilanoTa-Jen Liu
- Topics
- PI3K/AKT/mTOR signaling in cancer (4 papers)HER2/EGFR in Cancer Research (3 papers)Cancer-related Molecular Pathways (3 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Tiffany A. LaFortune
13 papers receiving 888 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 592
- Oncology 273
- Genetics 185
- Cancer Research 161
- Cell Biology 119
Countries citing papers authored by Tiffany A. LaFortune
This map shows the geographic impact of Tiffany A. LaFortune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany A. LaFortune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany A. LaFortune more than expected).
Fields of papers citing papers by Tiffany A. LaFortune
This network shows the impact of papers produced by Tiffany A. LaFortune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany A. LaFortune. The network helps show where Tiffany A. LaFortune may publish in the future.
Co-authorship network of co-authors of Tiffany A. LaFortune
This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany A. LaFortune. A scholar is included among the top collaborators of Tiffany A. LaFortune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany A. LaFortune. Tiffany A. LaFortune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 132 | |
| 3 | 17 | |
| 4 | 17 | |
| 5 | 5 | |
| 6 | 98 | |
| 7 | 102 | |
| 8 | 1 | |
| 9 | 203 | |
| 10 | 1 | |
| 11 | 185 | |
| 12 | 44 | |
| 13 | 75 |
About Tiffany A. LaFortune
Tiffany A. LaFortune is a scholar working on Immunology and Allergy, Oncology and Cell Biology, having authored 13 papers that have together received 902 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Immunology and Allergy (113 citations), Genetics (185 citations) and Cancer Research (161 citations). Tiffany A. LaFortune has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Dimpy Koul, John de Groot, W.K. Alfred Yung, Ningyi Tiao, W.K. Alfred Yung, Yuji Piao, Sauveur-Michel Maira, Vanessa Milano, Ta-Jen Liu and Osamu Ohmori. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.